Bumper Offer - Urjas oil Just @ Rs. 1
Rozavel A 150 Capsule is a prescription drug, available for use as Capsule. Rozavel A 150 Capsule also has some secondary and off-label uses. These are listed below.
The correct dosage of Rozavel A 150 Capsule depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Rozavel A 150 Capsule as well, which are listed below. Normally, these side effects of Rozavel A 150 Capsule are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Rozavel A 150 Capsule's effect is Severe during pregnancy and Severe for lactating mothers. In addition, Rozavel A 150 Capsule's effects on the liver, heart and kidney are discussed below in the Rozavel A 150 Capsule related warnings section.
Rozavel A 150 Capsule can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Rozavel A 150 Capsule in conditions like Kidney Disease, Hypothyroidism, Drug Allergy. The section on Rozavel A 150 Capsule contraindications lists all such conditions.
Additionally, Rozavel A 150 Capsule may also adversely react with other medicines. See below for a complete list.
In addition to these precautions, you may also note that Rozavel A 150 Capsule is safe while driving, and is is addictive in nature.
Rozavel A 150 Capsule is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Rozavel A 150 Capsule safe for pregnant women?
Rozavel A can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Rozavel A 150 Capsule safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Rozavel A. So it is adviced to consult the doctor before using it.
What is the effect of Rozavel A 150 Capsule on the Kidneys?
Rozavel A can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Rozavel A 150 Capsule on the Liver?
Rozavel A is not harmful for the liver.
What is the effect of Rozavel A 150 Capsule on the Heart?
The heart can be affected by Rozavel A. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Rozavel A 150 Capsule should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Rozavel A 150 Capsule unless your doctor advises you to do so -
Is this Rozavel A 150 Capsule habit forming or addictive?
Rozavel A 150 Capsule is not addictive in nature.
Interaction between Food and Rozavel A 150 Capsule
Due to the absence of research, it is difficult to say how Rozavel A 150 Capsule and food will interact.
Interaction between Alcohol and Rozavel A 150 Capsule
No research has been done on this till date. Therefore, it is not known what the effect of taking Rozavel A 150 Capsule with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194
